Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension

被引:81
|
作者
Kwapiszewska, G
Wilhelm, J
Wolff, S
Laumanns, I
Koenig, IR
Ziegler, A
Seeger, W
Bohle, RM
Weissmann, N
Fink, L [1 ]
机构
[1] Univ Giessen, Dept Pathol, Giessen, Germany
[2] Univ Luebeck, Dept Med Biometry & Stat, Lubeck, Germany
[3] Univ Giessen, Dept Internal Med, D-6300 Giessen, Germany
关键词
D O I
10.1186/1465-9921-6-109
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Chronic hypoxia influences gene expression in the lung resulting in pulmonary hypertension and vascular remodelling. For specific investigation of the vascular compartment, laser-microdissection of intrapulmonary arteries was combined with array profiling. Methods and Results: Analysis was performed on mice subjected to 1, 7 and 21 days of hypoxia (FiO(2) = 0.1) using nylon filters ( 1176 spots). Changes in the expression of 29, 38, and 42 genes were observed at day 1, 7, and 21, respectively. Genes were grouped into 5 different classes based on their time course of response. Gene regulation obtained by array analysis was confirmed by real-time PCR. Additionally, the expression of the growth mediators PDGF-B, TGF-beta, TSP-1, SRF, FGF-2, TIE-2 receptor, and VEGF-R1 were determined by real-time PCR. At day 1, transcription modulators and ion-related proteins were predominantly regulated. However, at day 7 and 21 differential expression of matrix producing and degrading genes was observed, indicating ongoing structural alterations. Among the 21 genes upregulated at day 1, 15 genes were identified carrying potential hypoxia response elements (HREs) for hypoxia-induced transcription factors. Three differentially expressed genes (S100A4, CD36 and FKBP1a) were examined by immunohistochemistry confirming the regulation on protein level. While FKBP1a was restricted to the vessel adventitia, S100A4 and CD36 were localised in the vascular tunica media. Conclusion: Laser-microdissection and array profiling has revealed several new genes involved in lung vascular remodelling in response to hypoxia. Immunohistochemistry confirmed regulation of three proteins and specified their localisation in vascular smooth muscle cells and fibroblasts indicating involvement of different cells types in the remodelling process. The approach allows deeper insight into hypoxic regulatory pathways specifically in the vascular compartment of this complex organ.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] A role for the serotonin transporter in hypoxia-induced pulmonary hypertension
    Fanburg, BL
    Lee, SL
    JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11): : 1521 - 1523
  • [42] Hypereapnia attenuates intermittent hypoxia-induced pulmonary hypertension
    Norton, Charles Elbert
    Snow, Jessica B.
    Kanagy, Nancy L.
    Walker, Benjimen R.
    Resta, Thomas C.
    FASEB JOURNAL, 2007, 21 (06): : A1436 - A1436
  • [43] Angiotensin converting enzyme expression in increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension (vol 96, pg 1823, 1995)
    Morrell, NW
    Atochina, EN
    Morris, KG
    Danilov, SM
    Stenmark, KR
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (01): : 271 - 271
  • [44] Pravastatin inhibits onocrotaline-induced pulmonary hypertension but not hypoxia-induced pulmonary hypertension in rats
    Hongo, M
    Sakai, A
    Ruan, Z
    Mawatari, E
    Yazaki, Y
    Kinoshita, O
    Kubo, K
    CIRCULATION, 2003, 108 (17) : 10 - 10
  • [45] Expression of endothelin-1 in rats developing hypobaric hypoxia-induced pulmonary hypertension
    Nakanishi, K
    Tajima, F
    Nakata, Y
    Osada, H
    Tachibana, S
    Kawai, T
    Torikata, C
    Suga, T
    Takishima, K
    Aurues, T
    Ikeda, T
    LABORATORY INVESTIGATION, 1999, 79 (11) : 1347 - 1357
  • [46] Chloroquine Is a Potent Pulmonary Vasodilator and Attenuates Hypoxia-Induced Pulmonary Hypertension
    Duan, X.
    Yang, W.
    Wang, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [47] Chloroquine Is a Potent Pulmonary Vasodilator that Attenuates Hypoxia-Induced Pulmonary Hypertension
    Wu, Kang
    FASEB JOURNAL, 2017, 31
  • [48] Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertension
    Wu, Kang
    Zhang, Qian
    Wu, Xiongting
    Lu, Wenju
    Tang, Haiyang
    Liang, Zhihao
    Gu, Yali
    Song, Shanshan
    Ayon, Ramon J.
    Wang, Ziyi
    McDermott, Kimberly M.
    Balistrieri, Angela
    Wang, Christina
    Black, Stephen M.
    Garcia, Joe G. N.
    Makino, Ayako
    Yuan, Jason X-J
    Wang, Jian
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (22) : 4155 - 4172
  • [49] Hypoxia-Induced Pulmonary Hypertension Coordinately Activates Cardiac and Pulmonary Fibroblasts
    Brown, R. D.
    Ambler, S. K.
    Long, C. S.
    Stenmark, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [50] EFFECT OF PHOSPHODIESTERASE 5(PDE5) ANTAGONISTS ON PULMONARY AND CEREBRAL ARTERIES OF PIGLETS WITH HYPOXIA-INDUCED PULMONARY HYPERTENSION
    Fike, Candice Denise
    Kaplowitz, Mark R.
    Zhang, Yongmei
    Dantuma, Mark
    Madden, Jane A.
    JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 263 - 263